Daraprim and the Morality of Healthcare Markets

The recent story about Turing Pharmaceuticals purchasing the rights to Daraprim - a uniquely effective¬†drug for a particular parasitic infection that is especially important for people with compromised immune systems (i.e. those with diseases like AIDS) - and raising the cost from $13.50 to $750 per pill is illustrative of, as Michael Sandel would say, … Continue reading Daraprim and the Morality of Healthcare Markets